Article
Mycophenolate revisited.
Transplant international : official journal of the European Society for Organ Transplantation - 1 May 2015
van Gelder Teun, Hesselink Dennis A
Abstract excerpt
The patent of mycophenolate mofetil (MMF) has expired, and for enteric-coated mycophenolate sodium (EC-MPS), this will happen in 2017. In the twenty years these drugs have been used, they have become extremely popular. In this review, the reasons for the popularity of mycophenolate are discussed, including the benefits compared to azathioprine. MMF and EC-MPS are therapeutically equivalent. Although neither is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
